Source link : https://newshealth.biz/health-news/gene-therapy-supply-runs-out-company-warns-of-treatment-delays/
Etranacogene dezaparvovec (Hemgenix), the only commercially available gene therapy for hemophilia B, is temporarily unavailable, according to maker CSL Behring. In a letter addressed to the hemophilia B community, the company said it is experiencing a “temporary global stockout” of the one-time gene therapy that will result in treatment delays for some patients in countries […]
The post Gene Therapy Supply Runs Out, Company Warns of Treatment Delays first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-21 15:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8